Effexor
Product Images NDC 0008-0836

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Effexor (NDC 0008-0836). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Effexorxr 01)

A chart depicting the pharmacokinetic fold changes and 90% confidence intervals of venlafaxine (Effexor XR) in the presence of various interacting drugs, including ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium. The graph shows changes in Cmax and AUC relative to a reference value, alongside clinical recommendations such as dose adjustments or cautions.*

FDA Label Image

Figure 2 (Effexorxr 02)

A dot plot chart showing pharmacokinetic fold changes (Cmax and AUC) and 90% confidence intervals for various analytes when co-administered with different interacting drugs. The x-axis represents the change relative to a reference value, ranging from 0 to 3. A text summary provides clinical recommendations such as dose adjustments or cautions for each drug interaction.*

FDA Label Image

Figure 3 (Effexorxr 03)

A scatter plot chart displaying pharmacokinetic fold changes and 90% confidence intervals for venlafaxine and its metabolite ODV in various special populations, including hepatic impairment, renal impairment, CYP2D6 polymorphisms, age above 60 years, and gender, with corresponding dosing recommendations based on changes relative to reference values.*

FDA Label Image

Chemical Structure (Effexorxr 04)

Chemical structure diagram of venlafaxine hydrochloride, the active ingredient in Effexor XR, showing molecular components and arrangement.*

FDA Label Image

Logo (Effexorxr 05)

FDA Label Image

Logo (Effexorxr 05a)

FDA Label Image

Principal Display Panel (37.5 mg Capsule Bottle Label)

Label for Effexor XR extended-release capsules containing 37.5 mg venlafaxine HCl. The label shows 30 capsules per package, with the product distributed by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. It includes storage instructions and a barcode with NDC 0008-0837-21.*

FDA Label Image

Principal Display Panel (37.5 mg Capsule Blister Pack)

Label sheet for Effexor XR 37.5 mg extended-release capsules by Wyeth Pharmaceuticals LLC. Each label displays the proprietary name, active ingredient venlafaxine HCl, strength of 37.5 mg, dosage form as extended-release capsules, and manufacturer details (Wyeth Phila. PA 19101). The labels also include space for expiration date, lot number, and a barcode.*

FDA Label Image

Principal Display Panel (37.5 mg Capsule Blister Pack Carton)

Packaging label for Effexor XR 37.5 mg extended-release capsules by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. The label indicates 100 capsules in 10 Redipak blister strips of 10 capsules each. The label features the Pfizer logo, dosage strength, and handling instructions including storage at controlled room temperature and dispensing with medication guide.*

FDA Label Image

Principal Display Panel (75 mg Capsule Bottle Label)

Label for Effexor XR 75 mg extended-release capsules by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. The label includes dosage strength, quantity of 30 capsules, storage instructions (20° to 25°C), and states the product is Rx only. It also specifies each capsule contains venlafaxine HCl equivalent to 75 mg venlafaxine and notes distribution from Philadelphia, PA.*

FDA Label Image

Principal Display Panel (75 mg Capsule Blister Pack)

Label for Effexor XR 75 mg extended-release capsules containing venlafaxine HCl. The label includes the proprietary name, strength, dosage form, and active ingredient. It shows the labeler as Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., based in Philadelphia, PA. Several identical labels are arranged in a grid format, each with barcode, lot, and expiration date area.*

FDA Label Image

Principal Display Panel (75 mg Capsule Blister Pack Carton)

Packaging label for Effexor XR 75 mg extended-release capsules by Wyeth Pharmaceuticals LLC, a Pfizer subsidiary. The label shows 10 Redipak blister strips with 10 capsules each, totaling 100 capsules. Storage information and dosage notes are included, along with barcodes and manufacturing details indicating the product is made in Switzerland.*

FDA Label Image

Principal Display Panel (150 mg Capsule Bottle Label)

Label for Effexor XR (venlafaxine HCl) extended-release capsules, 150 mg strength, containing 30 capsules per package. The label states it is manufactured in Switzerland and distributed by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., Philadelphia, PA. It includes storage instructions, dosage information, and a barcode.*

FDA Label Image

Principal Display Panel (150 mg Capsule Blister Pack)

Effexor XR 150 mg (venlafaxine HCl) extended-release capsules label strip featuring multiple identical labels. Each label shows the product name, active ingredient, strength, dosage form, Wyeth Pharmaceuticals LLC as the labeler, along with space for expiration and lot number barcode information.*

FDA Label Image

Principal Display Panel (150 mg Capsule Blister Pack Carton)

Packaging label for Effexor XR 150 mg extended-release capsules by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. The box contains 100 capsules in 10 Redipak blister strips of 10 capsules each. The label includes storage instructions and dosage guidance, emphasizing that it is a multiple dispensing package not for household use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.